dc.creatorSahasrabudhe, Ruta
dc.creatorLott, Paul
dc.creatorBohorquez, Mabel
dc.creatorToal, Ted
dc.creatorEstrada, Ana P.
dc.creatorSuarez, John J.
dc.creatorBrea Fernández, Alejandro
dc.creatorCameselle Teijeiro, José
dc.creatorPinto, Carla
dc.creatorRamos, Irma
dc.creatorMantilla, Alejandra
dc.creatorPrieto, Rodrigo
dc.creatorCorvalan, Alejandro
dc.creatorNorero, Enrique
dc.creatorAlvarez, Carolina
dc.creatorTapia, Teresa
dc.creatorCarvallo, Pilar
dc.creatorGonzalez, Luz M.
dc.creatorCock-Rada, Alicia
dc.creatorSolano, Angela Rosario
dc.creatorNeffa, Florencia
dc.creatorDella Valle, Adriana
dc.creatorYau, Chris
dc.creatorSoares, Gabriela
dc.creatorBorowsky, Alexander
dc.creatorHu, Nan
dc.creatorHe, Li-Ji
dc.creatorHan, Xiao-You
dc.creatorTaylor, Philip R.
dc.creatorGoldstein, Alisa M.
dc.creatorTorres, Javier
dc.creatorEcheverry, Magdalena
dc.creatorRuiz-Ponte, Clara
dc.creatorTeixeira, Manuel R.
dc.creatorCarvajal Carmona, Luis G.
dc.date.accessioned2018-04-09T21:44:42Z
dc.date.accessioned2018-11-06T11:11:27Z
dc.date.available2018-04-09T21:44:42Z
dc.date.available2018-11-06T11:11:27Z
dc.date.created2018-04-09T21:44:42Z
dc.date.issued2017-04
dc.identifierSahasrabudhe, Ruta; Lott, Paul; Bohorquez, Mabel; Toal, Ted; Estrada, Ana P.; et al.; Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer; W B Saunders Co-Elsevier Inc; Gastroenterology; 152; 5; 4-2017; 983-986
dc.identifier0016-5085
dc.identifierhttp://hdl.handle.net/11336/41447
dc.identifierCONICET Digital
dc.identifierCONICET
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1846921
dc.description.abstractUp to 10% of cases of gastric cancer are familial, but so far, only mutations in CDH1 have been associated with gastric cancer risk. To identify genetic variants that affect risk for gastric cancer, we collected blood samples from 28 patients with hereditary diffuse gastric cancer (HDGC) not associated with mutations in CDH1 and performed whole-exome sequence analysis. We then analyzed sequences of candidate genes in 333 independent HDGC and non-HDGC cases. We identified 11 cases with mutations in PALB2, BRCA1, or RAD51C genes, which regulate homologous DNA recombination. We found these mutations in 2 of 31 patients with HDGC (6.5%) and 9 of 331 patients with sporadic gastric cancer (2.8%). Most of these mutations had been previously associated with other types of tumors and partially co-segregated with gastric cancer in our study. Tumors that developed in patients with these mutations had a mutation signature associated with somatic homologous recombination deficiency. Our findings indicate that defects in homologous recombination increase risk for gastric cancer.
dc.languageeng
dc.publisherW B Saunders Co-Elsevier Inc
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1053/j.gastro.2016.12.010
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://www.gastrojournal.org/article/S0016-5085(16)35521-4/fulltext
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectINTERACTION
dc.subjectSTOMACH
dc.subjectTUMOR
dc.subjectWES
dc.titleGermline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer
dc.typeArtículos de revistas
dc.typeArtículos de revistas
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución